| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Avenue Therapeutics, Inc. (ATXI) has 0 insiders with recent SEC Form 4 filings, including 13 buys and 2 sells. ATXI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2020 | Herskowitz Neil | Director | Buy | 2,561 | $8.23 | $21,085.53 | +1.1% | |
| Feb 25, 2020 | Herskowitz Neil | Director | Buy | 10,000 | $9.31 | $93,100.00 | +9.1% | |
| Feb 25, 2020 | Vazzano Joseph Walter75 | Chief Financial Officer | Buy | 1,200 | $9.09 | $10,908.00 | +2.1% | |
| Sep 12, 2019 | Ingram Elizabeth Garrett | Director | Buy | 16,000 | $6.27 | $100,320.00 | New | |
| Aug 9, 2019 | Vazzano Joseph Walter75 | Chief Financial Officer | Sell | 4,688 | $5.59 | $26,204.06 | -3.9% | |
| Jun 18, 2019 | Herskowitz Neil | Director | Buy | 5,000 | $5.86 | $29,300.00 | +2.6% | |
| Apr 15, 2019 | Herskowitz Neil | Director | Buy | 1,000 | $4.52 | $4,520.00 | +1.1% | |
| Mar 29, 2019 | Herskowitz Neil | Director | Buy | 2,000 | $5.11 | $10,220.00 | +1.1% | |
| Feb 25, 2019 | Herskowitz Neil | Director | Buy | 5,000 | $5.46 | $27,300.00 | +5.8% | |
| Feb 5, 2019 | Herskowitz Neil | Director | Buy | 8,850 | $5.88 | $52,044.50 | +5.4% |